Bharat Biotech's typhoid conjugate vaccine shows nearly 82% efficacy at 12 months in a Phase-3 trail carried out in Nepal. It can be be given to babies as young as six months. Currently available typhoid vaccines have 60-70% efficacy and cannot be given to children younger than two years. A typhoid vaccine (Typbar TCV) developed … Continue reading Bharat Biotech’s typhoid conjugate vaccine offers 82% protection